Form 4: Bayview Legacy Sells Arteris Shares Under 10b5-1 Plan

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported the sale of 17,884 common shares at a weighted average price of $17.8357 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Bayview Legacy, LLC, identified as a 10% owner of Arteris, Inc. (AIP), reported a sale of common stock.
• The transaction involved the disposition of 17,884 shares of Arteris, Inc. common stock.
• The shares were sold at a weighted average price of $17.8357 per share, with individual sales ranging from $17.75 to $18.04.
• The sale was executed on January 15, 2026, pursuant to a Rule 10b5-1 trading plan adopted by Bayview Legacy, LLC on March 5, 2025.
• Following this transaction, Bayview Legacy, LLC beneficially owns 9,399,071 shares of Arteris, Inc. common stock.
• K. Charles Janac, as the manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares and has filed a separate Form 4 for the same transaction.

Sentiment

Score: 4

Explanation: The sale by a 10% owner, even if pre-planned under a 10b5-1 plan, can be interpreted with slight negative sentiment by the market, as it represents a reduction in insider holdings. However, the pre-planned nature mitigates immediate concerns.

Positives

• The transaction was conducted under a pre-arranged 10b5-1 trading plan, indicating a systematic and pre-planned disposition rather than an immediate reaction to new information.

Negatives

• A 10% owner, Bayview Legacy, LLC, sold a significant number of shares (17,884), which could be perceived as a negative signal by some investors.

Risks

• No new risks are disclosed in this transactional filing, which primarily reports an insider stock transaction.

Future Outlook

This transactional filing does not contain forward-looking statements or guidance regarding Arteris, Inc.'s future performance or outlook.

Management Comments

• K. Charles Janac, as the manager of Bayview Legacy, LLC, signed the filing, indicating his control over the reported beneficial ownership.

Industry Context

This filing reports an insider transaction specific to Arteris, Inc. and does not provide broader industry context or trends.

Comparison to Industry Standards

• Not applicable as this filing reports an insider transaction, not operational or financial results that can be benchmarked against industry standards or comparable companies.

Related Party Transactions

• The sale of common stock by Bayview Legacy, LLC, a 10% owner, constitutes a related party transaction.

Stakeholder Impact

• Shareholders may interpret the sale by a significant owner as a signal, potentially influencing short-term trading decisions, although the pre-planned nature of the transaction under a 10b5-1 plan suggests it is not based on new, undisclosed information.

Key Dates

Recommendation

The filing reports a pre-planned insider sale by a 10% owner. While insider sales can sometimes be a negative signal, the execution under a Rule 10b5-1 plan adopted months prior suggests a systematic diversification or liquidity event rather than a reaction to adverse company-specific news. This single transaction, without additional context on company fundamentals or strategic shifts, does not warrant a change from a 'hold' recommendation.

Keywords

Arteris Inc., AIP, Bayview Legacy LLC, K. Charles Janac, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Beneficial Ownership, Equity Securities